Hypertension incidence after tap-water implementation: A 13-year follow-up study in the arseniasis-endemic area of southwestern Taiwan

Science of the Total Environment

Volumn 409, Issue 21, 2011, Pages 4528-4535

  Wang, Shu Li ^a,b   Li, Wan Fen ^a   Chen, Chien Jen ^c,d   Huang, Yeou Lih ^e   Chen, Jein Wen ^a   Chang, Kuang Hsi ^a   Tsai, Lih Yu ^e   Chou, Kai Ming ^f  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f INDIANA UNIVERSITY   (United States)

Author keywords

Arsenic; Environmental health; Hypertension; Obesity; Risk assessment; Water consumption

Indexed keywords

ARSENIC CONCENTRATION; ARSENIC EXPOSURE; ARTESIAN WELL; CARDIO-VASCULAR DISEASE; ENVIRONMENTAL HEALTH; FOLLOW-UP STUDIES; HYPERTENSION; LONGITUDINAL STUDY; OBESITY; RISK FACTORS; URINARY ARSENIC; WATER CONSUMPTION;

ARSENIC; BLOOD PRESSURE; DISEASES; HEALTH RISKS; RISK ASSESSMENT; WATER SUPPLY; WELLS;

POTABLE WATER;

ARSENIC; DRINKING WATER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TAP WATER; WELL WATER;

ARSENIC; ARTESIAN WELL; COHORT ANALYSIS; DRINKING WATER; HEALTH RISK; HYPERTENSION; OBESITY; RISK ASSESSMENT; RISK FACTOR; WATER USE;

ADULT; AGED; ARSENIC POISONING; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDEMIC DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESIDENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TAIWAN; WATER SUPPLY; WORLD HEALTH ORGANIZATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARSENIC; BLOOD PRESSURE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FEMALE; FLOW INJECTION ANALYSIS; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SPECTROPHOTOMETRY, ATOMIC; TAIWAN; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

TAIWAN;

EID: 80052522452     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2011.07.058     Document Type: Article

References (35)

1. Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease. Circ Res 2006, 99:692-705.
2. Biggs M.L., Haque R., Moore L., Smith A. Arsenic-laced water in Chile. Science 1998, 281:785.
3. Callow A.D. Cardiovascular disease 2005-the global picture. Vascul Pharmacol 2006, 45:302-307.
4. Chen C.W., Gibb H. Procedures for calculating cessation lag. Regul Toxicol Pharmacol 2003, 38:157-165.
5. Chen C.J., Hsueh Y.M., Lai M.S., Shyu M.P., Chen S.Y., Wu M.M., et al. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995, 25:53-60.
6. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
7. Department of Health: Executive Yuan Statistics of causes of death 1994-2003, Wen-Hui Press, Taipei, Taiwan.
8. Gillum R.F., Mussolino M.E., Madans J.H. Body fat distribution and hypertension incidence in women and men. The NHANES I Epidemiologic Follow-up Study. Int J Obes Relat Metab Disord 1998, 22:127-134.
9. Gus M., Fuchs S.C., Moreira L.B., Moraes R.S., Wiehe M., Silva A.F., et al. Association between different measurements of obesity and the incidence of hypertension. Am J Hypertens 2004, 17:50-53.
10. Hu G., Sarti C., Jousilahti P., Peltonen M., Qiao Q., Antikainen R., et al. The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke 2005, 36:2538-2543.
11. Huang Y.K., Tseng C.H., Huang Y.L., Yang M.H., Chen C.J., Hsueh Y.M. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol Appl Pharmacol 2007, 218:135-142.
12. Iseki K., Kimura Y., Wakugami K., Okumura K., Muratani H., Ikemiya Y., et al. Comparison of the effect of blood pressure on the development of stroke, acute myocardial infarction, and end-stage renal disease. Hypertens Res 2000, 23:143-149.
13. Kannel W.B. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996, 275:1571-1576.
14. Kuo T.L. Arsenic content of artesian well water in endemic area of chronic arsenic poisoning. Reports of institute of pathology 1964, 7-13. National Taiwan University College of Medicine, Taipei, Taiwan.
15. Lin T.H., Huang Y.L., Wang M.Y. Arsenic species in drinking water, hair, fingernails, and urine of patients with blackfoot disease. J Toxicol Environ Health A 1998, 53:85-93.
16. Lin M.C., Liao C.M., Liu C.W., Singh S. Bioaccumulation of arsenic in aquacultural large-scale mullet Liza macrolepis from blackfoot disease area in Taiwan. Bull Environ Contam Toxicol 2001, 67:91-97.
17. Lindberg A.L., Kumar R., Goessler W., Thirumaran R., Gurzau E., Koppova K., et al. Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ Health Perspect 2007, 115:1081-1086.
18. Lindberg A.L., Ekstrom E.C., Nermell B., Rahman M., Lonnerdal B., Persson L.A., et al. Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh. Environ Res 2008, 106:110-120.
19. Lo M.C., Hsen Y.C., Lin B.K. Arsenic content of underground water in Taiwan: second report 1977, Taiwan Provincial Institute of Environmental Sanitation, Taichung, Taiwan.
20. McCarty K.M., Chen Y.C., Quamruzzaman Q., Rahman M., Mahiuddin G., Hsueh Y.M., et al. Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions. Environ Health Perspect 2007, 115:341-345.
21. Mehler P.S., Coll J.R., Estacio R., Esler A., Schrier R.W., Hiatt W.R. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 2003, 107:753-756.
22. Nordstrom D.K. Public health. Worldwide occurrences of arsenic in ground water. Science 2002, 296:2143-2145.
23. Pi J., Yamauchi H., Sun G., Yoshida T., Aikawa H., Fujimoto W., et al. Vascular dysfunction in patients with chronic arsenosis can be reversed by reduction of arsenic exposure. Environ Health Perspect 2005, 113:339-341.
24. Rodgers A., Lawes C., MacMahon S. Reducing the global burden of blood pressure-related cardiovascular disease. J Hypertens Suppl 2000, 18:S3-S6.
25. Rose G.A., Blackburn H., Gillum R.F., Prineas R.J. Cardiovascular survey methods 1982, World Health Organization, Geneva, Switzerland.
26. Schläwicke Engström K., Broberg K., Concha G., Nermell B., Warholm M., Vahter M. Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina. Environ Health Perspect 2007, 115:599-605.
27. Smith A.H., Lopipero P.A., Bates M.N., Steinmaus C. Public health. Arsenic epidemiology and drinking water standards. Science 2002, 296:2145-2146.
28. SPSS Inc. SPSS for Windows 2001, Chicago.
29. Tseng C.H. Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan. Atherosclerosis 2008, 199:12-18.
30. Tseng C.H., Chong C.K., Tseng C.P., Hsueh Y.M., Chiou H.Y., Tseng C.C., et al. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol Lett 2003, 137:15-21.
31. Ueshima H., Zhang X.H., Choudhury S.R. Epidemiology of hypertension in China and Japan. J Hum Hypertens 2000, 14:765-769.
32. Wang C.H., Jeng J.S., Yip P.K., Chen C.L., Hsu L.I., Hsueh Y.M., et al. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 2002, 105:1804-1809.
33. Wang S.L., Chiou J.M., Chen C.J., Tseng C.H., Chou W.L., Wang C.C., et al. Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. Environ Health Perspect 2003, 111:155-159.
34. Yeh C.J., Pan W.H., Jong Y.S., Kuo Y.Y., Lo C.H. Incidence and predictors of isolated systolic hypertension and isolated diastolic hypertension in Taiwan. J Formos Med Assoc 2001, 100:668-675.
35. Yuan Y., Marshall G., Ferreccio C., Steinmaus C., Selvin S., Liaw J., et al. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol 2007, 166:1381-1391.